ORCL vs VEEV
ORCL: Oracle is a major enterprise technology powerhouse shifting its massive software footprint to a high-growth, AI-driven cloud infrastructure and applications platform. VEEV: Veeva provides the essential industry-cloud infrastructure that powers global life sciences companies throughout the entire drug development and commercialization lifecycle.
Side-by-side fundamentals
| Metric | ORCL | VEEV | Edge |
|---|---|---|---|
| Price as of 2026-10-08 close | $135.69 | $284.84 | |
| Market cap | $410.3B | $46.1B | |
| P/E as of 2026-10-08 | 23.15 | 50.39 | ORCL lower |
| PEG as of 2026-10-08, 3-year EPS CAGR to FY2026 | 0.97 | 2.30 | ORCL lower |
| Net margin FY2026, SEC XBRL | +25.4% | +28.4% | VEEV higher |
| Gross margin FY2026, SEC XBRL | n/a | +75.5% | |
| Operating margin FY2026, SEC XBRL | +30.6% | +28.7% | ORCL higher |
| ROE FY2026, SEC XBRL | +39.7% | +12.6% | ORCL higher |
| ROA FY2026, SEC XBRL | +6.5% | +10.1% | VEEV higher |
| Debt / equity as of 2026-09-02 | 3.01 | 0.00 | VEEV lower |
| Revenue growth (YoY) as of 2026-09-02 | +17.4% | +16.3% | ORCL higher |
| Revenue CAGR (3y) SEC XBRL | +10.5% | +14.0% | VEEV higher |
| Dividend yield as of 2026-09-02 | +1.4% | n/a | |
| Dividend streak (yrs) SEC XBRL | 17 | 0 | ORCL higher |
| Beta as of 2026-09-02 | 1.70 | 0.67 | |
| 1-year return as of 2026-10-08 close | -53.0% | -5.6% | VEEV higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-02 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-08.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.